Discontinued — last reported Q4 '24
Collaboration revenue — Deferred Revenue
Moderna Collaboration revenue — Deferred Revenue decreased by 14.3% to $6.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 82.4%, from $34.00M to $6.00M. Over 3 years (FY 2021 to FY 2024), Collaboration revenue — Deferred Revenue shows a downward trend with a -55.3% CAGR.
Analysis
How to read this metric
An increase suggests a growing backlog of committed partnership work, while a decrease indicates the company is successfully fulfilling its contractual obligations.
Detailed definition
This represents the portion of consideration received from collaboration partners that has not yet been recognized as re...
Peer comparison
Common in biotech and pharmaceutical firms with R&D partnerships; peers often report this as 'Deferred Revenue' or 'Contract Liabilities' within segment disclosures.
mrna_segment_collaboration_revenue_deferred_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $230.00M | $218.00M | $204.00M | $192.00M | $167.00M | $77.00M | $81.00M | $73.00M | $62.00M | $41.00M | $34.00M | $33.00M | $33.00M | $7.00M | $6.00M |
| QoQ Change | — | -5.2% | -6.4% | -5.9% | -13.0% | -53.9% | +5.2% | -9.9% | -15.1% | -33.9% | -17.1% | -2.9% | +0.0% | -78.8% | -14.3% |
| YoY Change | — | — | — | — | -27.4% | -64.7% | -60.3% | -62.0% | -62.9% | -46.8% | -58.0% | -54.8% | -46.8% | -82.9% | -82.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's collaboration revenue — deferred revenue?
- Moderna (MRNA) reported collaboration revenue — deferred revenue of $6.00M in Q4 2024.
- How has Moderna's collaboration revenue — deferred revenue changed year-over-year?
- Moderna's collaboration revenue — deferred revenue decreased by 82.4% year-over-year, from $34.00M to $6.00M.
- What is the long-term trend for Moderna's collaboration revenue — deferred revenue?
- Over 3 years (2021 to 2024), Moderna's collaboration revenue — deferred revenue has grown at a -55.3% compound annual growth rate (CAGR), from $887.00M to $79.00M.
- What does collaboration revenue — deferred revenue mean?
- Revenue received from partners for services that have not yet been performed.